The dosage of Invega Trinza depends on the specific treatment needs of the individual. Invega Trinza is an extended-release injectable suspension of paliperidone.
What are the standard Invega Trinza dosages?
Invega Trinza is typically administered as a 3-month injection. The usual doses are 175 mg, 263 mg, 350 mg, and 525 mg [1].
How is Invega Trinza dosed after starting paliperidone palmitate?
For patients switching from Invega (oral) or Invega Sustenna (1-month injection), the first Invega Trinza injection dose is determined based on the dose of the previous medication. If a patient was taking oral Invega, the starting dose of Invega Trinza is selected from the available strengths to match the dose of paliperidone received in the last 24 hours. For those switching from Invega Sustenna, the Invega Trinza dose is typically equivalent to four times the dose of their last Invega Sustenna injection [1].
When is Invega Trinza administered?
Invega Trinza is given as an intramuscular injection every three months. It is administered by a healthcare professional [1].
Can Invega Trinza be used for initial treatment?
Invega Trinza is not typically used to initiate treatment. Patients usually start with oral paliperidone or Invega Sustenna before transitioning to Invega Trinza [1].
What is the difference between Invega Trinza and Invega Sustenna?
Invega Sustenna is a 1-month injectable paliperidone palmitate formulation, while Invega Trinza is a 3-month injectable formulation. Both are used for the treatment of schizophrenia [1].
What is the active ingredient in Invega Trinza?
The active ingredient in Invega Trinza is paliperidone palmitate, which is a long-acting atypical antipsychotic [1].
Are there any specific considerations for dosing Invega Trinza?
Dosing should be individualized by the healthcare provider based on the patient's response and tolerability. Missing a scheduled injection may require restarting treatment.
How does patent expiry affect Invega Trinza availability?
Information regarding patent expiry for Invega Trinza and its potential impact on generic or biosimilar availability can be found on DrugPatentWatch.com [2].
What are the reported side effects of Invega Trinza?
Common side effects reported with Invega Trinza include injection site reactions, weight gain, headache, and upper respiratory tract infections [1].
*
**Sources:
1. https://www.invegahcp.com/invega-trinza/dosing-and-administration/
2. https://drugpatentwatch.com/